Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy - Wikidata - awgldk - TriplyDB

Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy

Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy

http://www.wikidata.org/entity/Q26766115

about

Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection.ANA testing in the presence of acute and chronic infections.IMP/GTP balance modulates cytoophidium assembly and IMPDH activity.

P2860

Q37413335-8FE3C626-60AE-4A75-BF57-582CD670902B Q38799673-34EA6F19-2408-4BF5-A6DD-BBAA6447D00F Q55382907-288B842E-434F-48CF-AF80-5A6305317168

P2860

Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy

http://www.wikidata.org/entity/Q26766115

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Anti-rods/rings autoantibody g ...... interferon-α/ribavirin therapy

@ast

Anti-rods/rings autoantibody g ...... interferon-α/ribavirin therapy

@en

Anti-rods/rings autoantibody g ...... interferon-α/ribavirin therapy

@nl

type

label

Anti-rods/rings autoantibody g ...... interferon-α/ribavirin therapy

@ast

Anti-rods/rings autoantibody g ...... interferon-α/ribavirin therapy

@en

Anti-rods/rings autoantibody g ...... interferon-α/ribavirin therapy

@nl

prefLabel

Anti-rods/rings autoantibody g ...... interferon-α/ribavirin therapy

@ast

Anti-rods/rings autoantibody g ...... interferon-α/ribavirin therapy

@en

Anti-rods/rings autoantibody g ...... interferon-α/ribavirin therapy

@nl

P1433

Q26766115-34233669-6A51-45D9-8A02-E7667B91CD46

P1476

Q26766115-F58CD8A8-0CC5-4E68-9CBF-2B5A86A73A06

P2093

Q26766115-076ECF65-AC91-4CA8-9C9C-A334E5D17543

Q26766115-7281629D-7A3B-4C79-A60D-C6CC158C03B6

Q26766115-E1D31A56-E6EE-4E74-BF80-64B70BD44BC8

Q26766115-F227CDC0-318C-4E66-B114-930F4301A2D0

P2860

Q26766115-01D30BCD-C4A2-47FC-A597-06BDEF7A8BEA

Q26766115-02736F43-2B7F-4848-9B28-B5F9ADB6A17B

Q26766115-038DCAF2-9C47-489A-A245-19AA42B4093B

Q26766115-15884D5B-1AEB-4B2B-94FB-CE7824DC11BF

Q26766115-18CA0062-EB08-473C-B39A-C9860BEB20E9

Q26766115-2244AAFA-250D-4FE5-8950-1868875155CD

Q26766115-258D717F-D59E-40A6-A106-0A2826328A97

Q26766115-29C5306E-1DFC-4BF3-B981-31C5B0C9B45A

Q26766115-2A3A053C-B3B9-4939-A29C-1A026D5CA2B2

Q26766115-381EC54F-2325-4EFD-89A1-775BF1F4F381

P304

Q26766115-1DEEB7EA-CFDF-4A10-AEEB-58F45F439041

P31

Q26766115-7E7FCF45-2686-4235-9E50-26DA1A10ACBD

P3181

Q26766115-67E10670-A7B5-44DC-AC37-60432E5B5FCE

P356

Q26766115-506261D2-F8B2-4BB6-B0FB-65F8C6BB0380

P407

Q26766115-04052307-0F5D-422D-AAD0-9F3F041BCD92

P433

Q26766115-FD45A314-BBF7-49E5-8A34-500DDD9170B5

P478

Q26766115-47B39826-0FDF-40D7-9DB5-6D3A952A1C62

P50

Q26766115-8B46B5C4-EB55-4677-B5CB-0A56A4361B0F

Q26766115-B1CA85C1-F94F-4D79-8755-5497CC4000F2

Q26766115-CFA8B6BD-7539-43B3-86D6-1E68EB6CD7F2

Q26766115-D3F00686-7828-4963-BDA6-E3CC4AF1FA21

P577

Q26766115-F390E37D-FB3D-485C-AADB-6F906E50E767

P5875

Q26766115-73E6FFCC-F800-4886-AE88-48F3F04516E8

P698

Q26766115-7849DF21-E9A6-4586-B359-9925C6A44217

P921

Q26766115-EB0E92D7-8FBD-4F04-BE4E-066CBF51C0E6

P932

Q26766115-20310438-7ABD-4B86-B669-19FE72B666E1

P3181

P356

WJG.V22.I6.1966

P1433

World Journal of Gastroenterology

P1476

Anti-rods/rings autoantibody g ...... interferon-α/ribavirin therapy

@en

P2093

Edward K L Chan

http://www.w3.org/2001/XMLSchema#string

Gerson Dierley Keppeke

http://www.w3.org/2001/XMLSchema#string

Luis Eduardo C Andrade

http://www.w3.org/2001/XMLSchema#string

S John Calise

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells

Large-scale filament formation inhibits the activity of CTP synthetase

Microinjection of specific anti-IMPDH2 antibodies induces disassembly of cytoplasmic rods/rings that are primarily stationary and stable structures

Two distinct cDNAs for human IMP dehydrogenase

Enzymatic amination of uridine triphosphate to cytidine triphosphate

Isoforms of human CTP synthetase

Increased cytidine 5'-triphosphate synthetase activity in rat and human tumors

Intracellular compartmentation of CTP synthase in Drosophila

Human interferons alpha, beta and omega

Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon

P304

1966-1974

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2573621

http://www.w3.org/2001/XMLSchema#string

P356

10.3748/WJG.V22.I6.1966

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Gerson Dierley Keppeke

Luis E. Andrade

P577

2016-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292187688

http://www.w3.org/2001/XMLSchema#string

P698

26877604

http://www.w3.org/2001/XMLSchema#string

P921

P932

4726672

http://www.w3.org/2001/XMLSchema#string